✦ LIBER ✦

P71 A randomised, double-blinded, placebo-controlled pilot study assessing the safety and tolerability of Arimoclomol in sporadic inclusion body myositis (IBM)

✍ Scribed by P. Machado; A. Miller; M. Parton; L. Dewar; J.L. Holton; M. Dimachkie; L. Herbelin; L. Greensmith; R. Barohn; M.G. Hanna

Book ID: 117670389
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 43 KB
Volume: 21
Category: Article
ISSN: 0960-8966
DOI: 10.1016/s0960-8966(11)70090-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled study assessing the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary disease

✍ Bruce M. Prenner MD, Stan Bukofzer MBBCh, MMed (Int), Sarah Behm BS, Kathleen Fe 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 343 KB

Efficacy, safety, and tolerance of the n

Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study

✍ Pinter, M M; Pogarell, O; Oertel, W H 📂 Article 📅 1999 🏛 BMJ Publishing Group 🌐 English ⚖ 195 KB

A double-blind, randomised- placebo, con

A double-blind, randomised- placebo, controlled, parallel group, multicentre, flexible-dose escalation study to assess the efficacy and safety of sildenafil administered as required to male outpatients with erectile dysfunction in Korea

✍ Choi, H K; Ahn, T Y; Kim, J J; Kim, S C; Paick, J S; Suh, J K; Kim, H S; Kim, Y 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 183 KB

A placebo-controlled, double-blind, dose

A placebo-controlled, double-blind, dose-escalation study to assess the safety, tolerability and pharmacokinetics/pharmacodynamics of single and multiple intravenous infusions of AZD9773 in patients with severe sepsis and septic shock

✍ Peter E Morris; Brian Zeno; Andrew C Bernard; Xiangning Huang; Shampa Das; Timi 📂 Article 📅 2012 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 300 KB

P2-377: A phase 2, double-blind, placebo

P2-377: A phase 2, double-blind, placebo-controlled study to evaluate the safety, tolerability, and effect on cognitive function of AL-108 after 12 weeks of intranasal administration in subjects with mild cognitive impairment

✍ Schmechel, Donald E.; Gerard, Gary; Vatakis, Nick G.; Harper, Linda; Ross, Joel 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 62 KB